Salute e Benessere
Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results
The dial-in number to access the call is U.S./ Canada (866) 497-0462, International (678) 509-7598, and the passcode is 4777677. Please dial in 10 minutes prior to the scheduled start time.
A replay of the call will be available from February 26, 2020 at 11:00 a.m. ET until 11:00 a.m. ET on March 4, 2020 by dialing U.S./ Canada (800) 585-8367 International (404) 537-3406, and entering the passcode 4777677.
A simultaneous webcast of the call can be accessed by visiting http://investor.endo.com/events-and-presentations. In addition, a replay of the webcast will be available on the Company website for one year following the event.
Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland , and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.